Metraipolis › archive › dc_bfffa023dc57

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy:… — Europe PMC PPR:PPR579535

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR579535
DOI
10.1101/2022.12.02.22283049
License (as archived)
solo-consultazione
Archived
2026-10-08T01:13:05.659Z
SHA-256 of the archived text
19ec9903355e0062cc32bbda8e63a2ebeb051d2c0d9cf965ed92a7482a01a6f3
Stable URL of this page
https://metraipolis.com/documento/dc_bfffa023dc57

How to cite

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy:… — Europe PMC PPR:PPR579535 — Europe PMC, https://europepmc.org/article/PPR/PPR579535 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfffa023dc57 (Metraipolis archive dc_bfffa023dc57, sha256 19ec9903355e0062cc32bbda8e63a2ebeb051d2c0d9cf965ed92a7482a01a6f3)
BibTeX
@misc{dcbfffa023dc57,
  title = {Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy:… — Europe PMC PPR:PPR579535},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR579535},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfffa023dc57; sha256 19ec9903355e0062cc32bbda8e63a2ebeb051d2c0d9cf965ed92a7482a01a6f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR579535. Agents can read the archived copy with the MCP tool read_document.